<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>64(4)</volume><submitter>Zuraik AA</submitter><pubmed_abstract>An intricate relationship exists, and interactions occur between the gut microbiota and colorectal cancer (CRC). Recent studies have indicated that inflammatory reactions stimulated by &lt;i>Fusobacterium nucleatum&lt;/i> (&lt;i>Fn&lt;/i>) lead to the development of CRC. Radical surgery combined with adjuvant chemotherapy is the primary treatment approach for most CRC patients. This study was designed to evaluate the abundance of &lt;i>Fn&lt;/i> as part of the gut microbiota in patients with CRC compared to healthy individuals and to assess the effect of the gut microbiota &lt;i>Fn&lt;/i> on patients undergoing adjuvant chemotherapy and those experiencing CRC relapse. There were 201 participants, comprising 50 healthy controls and 151 CRC patients. Stool samples were collected from three CRC groups (postoperative</pubmed_abstract><journal>Indian journal of microbiology</journal><pagination>1938-1950</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11645352</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Effect of Chemotherapy on &amp;lt;i&amp;gt;Fusobacterium nucleatum&amp;lt;/i&amp;gt; Abundance in Colorectal Cancer Patients: A Study on Relapsing Patients.</pubmed_title><pmcid>PMC11645352</pmcid><pubmed_authors>Daboul Y</pubmed_authors><pubmed_authors>Awama MA</pubmed_authors><pubmed_authors>Kayasseh MA</pubmed_authors><pubmed_authors>Zuraik AA</pubmed_authors><pubmed_authors>Georges M</pubmed_authors><pubmed_authors>Yazigi H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Chemotherapy on &amp;lt;i&amp;gt;Fusobacterium nucleatum&amp;lt;/i&amp;gt; Abundance in Colorectal Cancer Patients: A Study on Relapsing Patients.</name><description>An intricate relationship exists, and interactions occur between the gut microbiota and colorectal cancer (CRC). Recent studies have indicated that inflammatory reactions stimulated by &lt;i>Fusobacterium nucleatum&lt;/i> (&lt;i>Fn&lt;/i>) lead to the development of CRC. Radical surgery combined with adjuvant chemotherapy is the primary treatment approach for most CRC patients. This study was designed to evaluate the abundance of &lt;i>Fn&lt;/i> as part of the gut microbiota in patients with CRC compared to healthy individuals and to assess the effect of the gut microbiota &lt;i>Fn&lt;/i> on patients undergoing adjuvant chemotherapy and those experiencing CRC relapse. There were 201 participants, comprising 50 healthy controls and 151 CRC patients. Stool samples were collected from three CRC groups (postoperative</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-14T03:13:23.793Z</modification><creation>2026-06-14T03:08:39.24Z</creation></dates><accession>S-EPMC11645352</accession><cross_references><pubmed>39678992</pubmed><doi>10.1007/s12088-024-01279-6</doi></cross_references></HashMap>